Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Molecular Oncology

• Publication date

  2008-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.molonc.2008.09.006PMID 19383353PMCID PMC5527772
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells

  2008cited by this paper
• Unraveling the biology of multiple myeloma disease: cancer stem cells, acquired intracellular changes and interactions with the surrounding micro-environment.

  2008cited by this paper
• Curcumin: From ancient medicine to current clinical trials

  2008cited by this paper
• Bortezomib in multiple myeloma.

  2007cited by this paper
• The malignant clone and the bone-marrow environment.

  2007cited by this paper
• Using chemopreventive agents to enhance the efficacy of cancer therapy.

  2006cited by this paper
• The proteasome as a potential target for novel anticancer drugs and chemosensitizers.

  2006cited by this paper
• Bortezomib for multiple myeloma

  2006cited by this paper
• Bortezomib: A valuable new antineoplastic strategy in multiple myeloma

  2005cited by this paper
• Targeting Multiple Myeloma Cells and Their Bone Marrow Microenvironment

  2004cited by this paper
• Multiple myeloma

  2004cited by this paper
• Proteasome inhibitor PS-341 abrogates IL-6 triggered signaling cascades via caspase-dependent downregulation of gp130 in multiple myeloma

  2003cited by this paper
• The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents.

  2003cited by this paper
• Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis.

  2003cited by this paper
• A prospective, open-label safety and efficacy study of combination treatment with bortezomib (PS-341, velcade and melphalan in patients with relapsed or refractory multiple myeloma.

  2003cited by this paper
• Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis

  2003cited by this paper
• Molecular mechanisms of novel therapeutic approaches for multiple myeloma

  2002cited by this paper
• The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases.

  2002cited by this paper
• Multiple Myeloma. Advances in disease biology: therapeutic implications.

  2001cited by this paper
• Advances in disease biology: Therapeutic implications

  2001cited by this paper
• The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma.

  2000cited by this paper
• Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion.

  1993cited by this paper
• Multiple myeloma.

  1948cited by this paper

• Mechanistic and translational insights into plant-derived natural products in preclinical multiple myeloma research: Current evidence

  2026cites this paper
• Synergistic Mechanisms of Traditional Chinese Medicine and Proteasome Inhibitors in Multiple Myeloma Therapy: A Comprehensive Review

  2025cites this paper
• Exploring the anticancer potential of traditional herbs from Tamil Nadu: a narrative review of ethnomedicinal insights and scientific evidence

  2025cites this paper
• Hepatoprotection conferred by curcumin against emamectin benzoate-induced oxidative stress, biochemical, molecular, and histological disturbances in rats.

  2025cites this paper
• Transcriptomic and untargeted metabolomic studies on the anticoccidial activity of eugenol in broilers

  2025cites this paper
• Curcumin in treatment of hematological cancers: Promises and challenges

  2024cites this paper
• The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology.

  2024cites this paper
• Small-molecule inhibitors targeting FOXM1: Current challenges and future perspectives in cancer treatments.

  2023cites this paper
• A Review of The Synergistic Effects of Curcumin with Proteasome Inhibitors in Multiple Myeloma Preclinical Models

  2023cites this paper
• Synergistically Anti-Multiple Myeloma Effects: Flavonoid, Non-Flavonoid Polyphenols, and Bortezomib

  2022influential citation
• The effect of curcumin on some cytokines, antioxidants and liver function tests in rats induced by Aflatoxin B1

  2022cites this paper
• Molecular Mechanisms of Action of Eugenol in Cancer: Recent Trends and Advancement

  2022cites this paper
• Curcumin induces potent cytotoxic effects on myeloma cells independent of caspase activation

  2021cites this paper
• Curcumin Synergistically Enhances the Cytotoxicity of Arsenic Trioxide in U266 Cells by Increasing Arsenic Uptake

  2021cites this paper
• Pharmacological Properties and Health Benefits of Eugenol: A Comprehensive Review

  2021cites this paper
• Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer

  2021cites this paper
• Anti-Cancer Activity of Curcumin on Multiple Myeloma.

  2020cites this paper
• Phytochemicals in cancer cell chemosensitization: Current knowledge and future perspectives.

  2020cites this paper
• Drug repositioning for the treatment of hematologic disease: limits, challenges and future perspectives.

  2020cites this paper
• Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chronic Lymphocytic Leukemia Cells

  2019cites this paper
• Proteasome inhibition prevents cell death induced by the chemotherapeutic agent cisplatin downstream of DNA damage.

  2019cites this paper
• Targeting multiple myeloma with natural polyphenols.

  2019cites this paper
• Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-κB pathways.

  2018cites this paper
• The Potential of Curcumin: A Multitargeting Agent in Cancer Cell Chemosensitization

  2018cites this paper
• Effects of curcumin-/boron-based compound complexation on antioxidant and antiproliferation activity

  2018cites this paper
• Gambogenic acid synergistically potentiates bortezomib-induced apoptosis in multiple myeloma

  2017cites this paper
• Curcumin: An Effective Inhibitor of Interleukin-6.

  2017cites this paper
• Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies

  2017cites this paper
• Curcumin-bortezomib loaded polymeric nanoparticles for synergistic cancer therapy

  2017cites this paper
• Age-dependent sensitivity to anti-mitotics: the role of FoxM1 and its therapeutic potential

  2017cites this paper
• Nano-natural Products as Anticancer Agents

  2017cites this paper
• Multi-Targeted Agents in Cancer Cell Chemosensitization: What We Learnt from Curcumin Thus Far.

  2016cites this paper
• Nanobiomaterials in cancer therapy

  2016cites this paper
• Cinnamon extract exhibits potent anti-proliferative activity by modulating angiogenesis and cyclooxygenase in myeloma cells

  2016cites this paper
• UPDATES AND ADDITIONS for Herbal Contraindications &Drug Interactions plus Herbal Adjuncts with Medicines

  2016cites this paper
• Logic-Based and Cellular Pharmacodynamic Modeling of Bortezomib Responses in U266 Human Myeloma Cells

  2015cites this paper
• Curcumin and cancer stem cells: curcumin has asymmetrical effects on cancer and normal stem cells.

  2015cites this paper
• Curcumin Enhanced Busulfan-Induced Apoptosis through Downregulating the Expression of Survivin in Leukemia Stem-Like KG1a Cells

  2015cites this paper
• Curcumin and Its Analogue Induce Apoptosis in Leukemia Cells and Have Additive Effects with Bortezomib in Cellular and Xenograft Models

  2015cites this paper
• The Multifaceted Role of Curcumin in Cancer Prevention and Treatment

  2015cites this paper
• Curcumin and Interleukin-6 (IL-6)

  2015cites this paper
• Antineoplastic potential of curcumin (cooperative study in Bulgaria and Germany)

  2014cites this paper
• Effects of a novel proteasome inhibitor BU-32 on multiple myeloma cells

  2014cites this paper
• Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups

  2014cites this paper
• Inactivation of FoxM1 transcription factor contributes to curcumin-induced inhibition of survival, angiogenesis, and chemosensitivity in acute myeloid leukemia cells

  2014cites this paper
• The Molecular Basis for the Pharmacokinetics and Pharmacodynamics of Curcumin and Its Metabolites in Relation to Cancer

  2014cites this paper
• Augmented sensitivity to methotrexate by curcumin induced overexpression of folate receptor in KG-1 cells.

  2013cites this paper
• Dendrimer-curcumin conjugate: a water soluble and effective cytotoxic agent against breast cancer cell lines.

  2013cites this paper
• Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: biological insights and early treatment strategies.

  2013cites this paper
• Curcumin Inhibits TGF-β1-Induced MMP -9 and Invasion MDA-MB-231 Cells through ERK, Smad Signaling

  2013influential citation
• Targeting FOXM1 in cancer.

  2013cites this paper
• Understanding CAM Natural Health Products: Implications of Use Among Cancer Patients and Survivors

  2013cites this paper
• Cancer-linked targets modulated by curcumin.

  2012cites this paper
• Concurrent Sulforaphane and Eugenol Induces Differential Effects on Human Cervical Cancer Cells

  2012cites this paper
• Proteasome inhibition in cancer is associated with enhanced tumor targeting by the adeno‐associated virus/phage

  2012cites this paper
• Curcumin inhibits TGF-β1-induced MMP-9 and invasion through ERK and Smad signaling in breast cancer MDA- MB-231 cells.

  2012influential citation
• Epigenetic mechanisms of plant-derived anticancer drugs.

  2012cites this paper
• Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer.

  2012cites this paper
• Review Article Cancer-linked targets modulated by curcumin

  2012cites this paper
• A small molecule, LLL12 inhibits constitutive STAT3 and IL‐6‐induced STAT3 signaling and exhibits potent growth suppressive activity in human multiple myeloma cells

  2012cites this paper
• Curcumin Enhances Cytotoxic Effects of Bortezomib in Human Multiple Myeloma H929 Cells: Potential Roles of NF-κB/JNK

  2012cites this paper
• Sensitizing human multiple myeloma cells to the proteasome inhibitor bortezomib by novel curcumin analogs

  2011cites this paper
• No protective effect of curcumin on hydrogen peroxide-induced cytotoxicity in HepG2 cells.

  2011cites this paper
• Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells

  2011cites this paper
• Eugenol Enhances the Chemotherapeutic Potential of Gemcitabine and Induces Anticarcinogenic and Anti-inflammatory Activity in Human Cervical Cancer Cells

  2011cites this paper
• An Evidence-Based Perspective of Curcuma Longa (Turmeric) for Cancer Patients

  2011cites this paper
• Synergistic apoptotic effect of arabinoxylan rice bran (MGN-3/Biobran) and curcumin (turmeric) on human multiple myeloma cell line U266 in vitro.

  2011cites this paper
• Curcuma as a functional food in the control of cancer and inflammation

  2011cites this paper
• Development of early treatment strategies for high-risk myeloma precursor disease in the future.

  2011cites this paper
• Signal transducer and activator of transcription 3 pathway mediates genipin‐induced apoptosis in U266 multiple myeloma cells

  2011cites this paper
• Coformulation of doxorubicin and curcumin in poly(D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells.

  2011cites this paper
• Down-regulation of expression of interleukin-6 and its receptor results in growth inhibition of MCF-7 breast cancer cells.

  2011cites this paper
• Nanoparticle Delivery of Natural Products in the Prevention and Treatment of Cancers: Current Status and Future Prospects

  2011cites this paper
• Thiazole Antibiotic Thiostrepton Synergize with Bortezomib to Induce Apoptosis in Cancer Cells

  2011cites this paper
• Cytotoxic Effect of Syzgium aromaticum Extract and Gemcitabine on Human Cervical Cancer Cell Line~!2009-12-01~!2010-01-05~!2010-02-16~!

  2010cites this paper
• Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications.

  2010cites this paper
• Smoldering (asymptomatic) multiple myeloma: revisiting the clinical dilemma and looking into the future.

  2010cites this paper
• Herbs in hemato-oncological care: an evidence-based review of data on efficacy, safety, and drug interactions

  2010cites this paper
• Effect of Toxic Metals on Human Health

  2010cites this paper
• Cadmium increases ferroportin-1 gene expression in J774 macrophage cells via the production of reactive oxygen species

  2009cites this paper
• Proteasome inhibitors in cancer therapy.

  2009cites this paper
• Prognostic significance of apoptotic index in multiple myeloma patients treated by conventional therapy and novel agents, thalidomide and bortezomib

  2009cites this paper
• Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231

  2009cites this paper
• Peroxisome proliferator‐activated receptor γ agonists potentiate the cytotoxic effect of valproic acid in multiple myeloma cells

  2009cites this paper
• Clove (Syzygium aromaticum) Extract Potentiates Gemcitabine Cytotoxic Effect on Human Cervical Cancer Cell Line

  2009cites this paper
• Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells

  2008cites this paper